Trial Profile
Randomized Trial of Simvastatin for the Treatment of Severe Asthma
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Simvastatin (Primary)
- Indications Asthma
- Focus Pharmacodynamics; Therapeutic Use
- 22 Sep 2017 Planned End Date changed from 1 Jul 2017 to 22 Aug 2017.
- 22 Sep 2017 Planned primary completion date changed from 1 Jul 2017 to 22 Aug 2017.
- 22 Sep 2017 Status changed from recruiting to discontinued.